SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Technical Chemical & Products (TCPI) -- Ignore unavailable to you. Want to Upgrade?


To: Vic who wrote (21)11/4/1997 7:30:00 PM
From: Rob E.  Read Replies (1) | Respond to of 111
 
Vic...please let me know what you find out when you hear from Ms. Reese, or the company. I'm in at an average of about $16. If this company does anything near what the one analyst says it will do, we should be well rewarded within 12 months, but with earnings so close, the concern you raise about some info leaking to the inside seems quite possible....I hope not.

Regards,
Rob



To: Vic who wrote (21)11/5/1997 10:36:00 PM
From: Brander  Read Replies (1) | Respond to of 111
 
Hi Vic; I spoke with TCPI IR today, and they do not have a message from you to return your call. I think that if you call them again, you will find them very forthcoming, and they will answer your questions clearly and honestly, IMO. I was told that they are very much on course with their noninvasive glucose monitoring system, and that it was displayed recently in two shows. This is the only operating noninvasive glucose monitoring system at this time, and it seems to me that TCPI is well ahead of anyone else as far as getting such a system to the market. From what I understand, they are currently working on correlating the readings from the patch to blood glucose. I think that is their remaining hurdle before sending it to the FDA. Anyway, Vic, please call TCPI and ask for Investor Relations. They do read this thread, and told me specificaly that they did not know how to get a hold of you to answer your questions.

Good luck, Brad